[1] 徐佳, 王萱, 游燕, 等. 钆塞酸二钠增强磁共振灌注与多期肝胆期成像定量评价大鼠肝纤维化[J]. 中国医学科学院学报, 2018, 40(6):809-816. [2] 周元, 陈橼, 尹必辉, 等. 吲哚菁绿试验联合Child-Pugh评分分级评估老年肝细胞癌患者围术期肝功能储备的价值[J]. 中国临床医学, 2018, 25(3):400-404. [3] 李琴, 王宝恩, 贾继东. 肝功能分级的演变及特点:从Child到MELD[J]. 中华肝脏病杂志, 2004, 12(5):319-320. [4] PURYSKO AS, REMER EM, VENIERO JC.Focal liver lesion detection and characterization with GD-EOB-DTPA[J]. Clinical radiology, 2011, 66(7):673-684. [5] VAN BEERS BE, PASTOR CM, HUSSAIN HK.Primovist, Eovist: what to expect?[J]. J hepatology, 2012 ,57(2):421-429 [6] NASSIF A, JIA J, KEISER M, et al.Visualization of hepatic uptake transporter function in healthy subjects by using gadoxetic acid-enhanced MR imaging[J]. Radiology, 2012, 264(3):741-50. [7] 周忠洋,向颜韩,廖锦元.钆塞酸二钠增强磁共振成像T1-mapping评估肝纤维化评分的研究[J/CD]. 新发传染病电子杂志, 2020, 5(3):178-182. [8] INFANTE-RIVARD C, ESNAOLA S, VILLENEUVE JP.Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics[J]. Hepatology, 1987, 7(4):660-664. [9] WILMAR DG, ROELOF JB, REETA V, et al.Nuclear imaging techniques for the assessment of hepatic function in liver surgery and transplantation[J]. J Nucl Med, 2010, 51(5):742-52. [10] 宋彬. 肝细胞特异性磁共振对比剂Gd-EOB-DTPA—新的机遇[J].放射学实践, 2016, 31(1):17-18. [11] 中华医学会肝病学分会. 肝硬化诊治指南[J]. 中华肝脏病杂志, 2019, 27(11):846-865. [12] 易永祥. 乙型肝炎病毒的分子流行病学研究进展[J/CD]. 新发传染病电子杂志, 2020, 5(1):1-7. [13] LEE S, DONGIL C, JEONG WK.Hepatic enhancement of Gd-EOB-DTPA-enhanced 3 Tesla MR imaging: Assessing severity of liver cirrhosis.Journal of magnetic resonance imaging[J]. JMRI, 2016, 44(5):1339-1345. [14] 李亮杰, 贾啟龙, 刘志飞, 等. 普美显增强CE-MRC对肝硬化患者肝功能评价的应用价值[J]. 中国医学创新, 2020, 17(16):22-26. [15] YOON JH, LEE JM, KANG H, et al.Quantitative Assessment of Liver Function by Using Gadoxetic Acid-enhanced MRI: Hepatocyte Uptake Ratio[J]. Radiology, 2019, 290(1):125-133. |